Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             155 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal brain morphology in MRI scans of first episode schizophrenics associated with poor treatment response Lieberman, J
1990
3 1 p. 19-
1 p.
artikel
2 Abnormal brain-stem auditory evoked potentials in schizophrenia: Correlations to symptomatology; genetics and csf monoamine metabolite levels Lindstrom, L.H.
1990
3 1 p. 56-
1 p.
artikel
3 A conceptual model of the schizophrenic syndrome: Implications for psychosocial treatments Sullivan, T
1990
3 1 p. 87-
1 p.
artikel
4 A decreased influx of tyrosine across the blood-brain barrier in patients with schizophrenia as determined by positron emission tomography Wiesel, F.A.
1990
3 1 p. 26-27
2 p.
artikel
5 A factor analytic study of ventriculomegaly in schizophrenia: An MRI study Schwarzkopf, SB
1990
3 1 p. 18-
1 p.
artikel
6 Akathisia variants: Prevalence and iron status in an inpatient population with chronic schizophrenia Barnes, T.R.E.
1990
3 1 p. 79-
1 p.
artikel
7 A ‘mock-up’ of schizophrenia: Temporal lobe epilepsy and schizophrenia-like psychosis Roberts, G.W.
1990
3 1 p. 94-
1 p.
artikel
8 An analysis of postmortem brain gene expression in schizophrenic and control subjects Perrett, C.W.
1990
3 1 p. 15-16
2 p.
artikel
9 An autoradiographic study in schizophrenia: Evidence for an altered laminar distribution of 3H-d-aspartate binding in orbito-frontal cortex Royston, M.C.
1990
3 1 p. 31-32
2 p.
artikel
10 An open trial of ondansetron (GR38032F) in the treatment of acute schizophrenia Williams, P.
1990
3 1 p. 48-
1 p.
artikel
11 Apomorphine effects on brain metabolism in neuroleptic naive first episode schizophrenics and normal controls Cleghorn, J.M.
1990
3 1 p. 25-
1 p.
artikel
12 A prospective study of the interaction between life events and neuroleptic medication on the course of schizophrenic symptoms Cramer, P.
1990
3 1 p. 11-
1 p.
artikel
13 A study of the social environment and clinical poverty in long stay chronic schizophrenic patients in a British Mental Hospital in 1988: A reassessment of institutionalism and schizophrenia Curson, D.
1990
3 1 p. 7-
1 p.
artikel
14 Auditory evoked potentials in chronic schizophrenics Eikelmann, B.
1990
3 1 p. 57-
1 p.
artikel
15 Author index 1990
3 1 p. 95-
1 p.
artikel
16 Behavior therapy with chronic schizophrenic patients: Special effects of a ‘cognitive’ and ‘social skills’ training program Hubmann, W
1990
3 1 p. 87-88
2 p.
artikel
17 Beta-blockers in schizophrenia: A review of the literature Ratey, J.
1990
3 1 p. 49-
1 p.
artikel
18 Biochemical pharmacology of the atypical neuroleptic remoxipride Kohler, C.
1990
3 1 p. 44-45
2 p.
artikel
19 Brain morphology in first episode cases of schizophrenia DeLisi, L.E.
1990
3 1 p. 20-
1 p.
artikel
20 Calcitonin gene-related pedtide in the amygdaloid complex of the rat: Immunohistochemical and quantitative distribution, and drug effects on calcium-dependent, potassium-evokedin vitro release Saria, A.
1990
3 1 p. 35-
1 p.
artikel
21 Can a neurodevelopmental framework provide an explanation for heterogeneity in schizophrenia? Murray, R.M.
1990
3 1 p. 17-
1 p.
artikel
22 Carbamazepine in chronic schizophrenic patients: Adjunct of carbamazepine to neuroleptic therapy Meszaros, K.
1990
3 1 p. 50-
1 p.
artikel
23 Catatonia as a life threatening disease at the intensive psychiatric care unit Basny, Z
1990
3 1 p. 73-
1 p.
artikel
24 Cerebral metabolic changes as a consequence of DA receptor blockade Tamminga, C.A.
1990
3 1 p. 25-
1 p.
artikel
25 Cerebral spect in drug free schizophrenic patients Vita, A
1990
3 1 p. 24-
1 p.
artikel
26 Characteristics of ‘normal’ controls who volunteer for schizophrenia research Olson, S.C.
1990
3 1 p. 92-
1 p.
artikel
27 Clinical and cognitive correlates of occulomotor abnormalities in schizophrenia Thaker, G.
1990
3 1 p. 60-
1 p.
artikel
28 Codetermination of medication as a step towards improved compliance: The patient's viewpoint 1990
3 1 p. 41-
1 p.
artikel
29 Cognitive and social treatment for chronic schizophrenic patients Merlo, M.C.G.
1990
3 1 p. 88-
1 p.
artikel
30 Cognitive functioning and symptomatology in chronic schizophrenia Nelson, H.E.
1990
3 1 p. 63-64
2 p.
artikel
31 Collaborative patient and staff treatment planning groups: Recognition of the limits and goals of treatment McCarthy, R.H.
1990
3 1 p. 86-87
2 p.
artikel
32 Combined serotonin 5-HT2 and dopamine D2 receptor antagonism in the treatment of schizophrenia Heylen, S.L.E.
1990
3 1 p. 46-47
2 p.
artikel
33 Comparison of spiperone binding to lymphocytes in schizophrenics, their first degree relatives and control subjects Griffiths, R.S.
1990
3 1 p. 31-
1 p.
artikel
34 CT abnormalities in early stage of schizophrenics Ohtani, Tsuyoshi
1990
3 1 p. 19-
1 p.
artikel
35 Current opinion about atypical compounds in schizophrenia Verhoeven, W.M.A.
1990
3 1 p. 41-
1 p.
artikel
36 D1- and D2-dopamine receptor occupancy during treatment with classical and atypical neurpleptics Farde, L.
1990
3 1 p. 51-52
2 p.
artikel
37 Decreased in vitro tyrosine transport in schizophrenic patients Bjerkenstedt, L.
1990
3 1 p. 38-
1 p.
artikel
38 Deficit and non-deficit schizophrenia: Sleep, occulomotor amd MRI studies Gerbaldo, H.
1990
3 1 p. 60-
1 p.
artikel
39 Different profile of the neuroleptic induced upregulation of the dopaminergic d2 receptors in nigrostriatal and mesolimbic systems Laruelle, M
1990
3 1 p. 29-30
2 p.
artikel
40 Different semantic information processing in schizophrenics Volz, H.-P.
1990
3 1 p. 55-56
2 p.
artikel
41 Differing time course of emergence of psychotic symptoms and dyskinesia after neuroleptic withdrawal Dixon, L
1990
3 1 p. 78-79
2 p.
artikel
42 Distributed brain glutamate and GABA mechanisms in schizophrenia Deakin, J.F.W.
1990
3 1 p. 33-
1 p.
artikel
43 Do neuroleptic drugs affect the accesibility of the CNS to exogenous psychoactive substances? Ramchand, C.N.
1990
3 1 p. 51-
1 p.
artikel
44 Dopamine receptor sensitivity and tardive-dyskinesia Yadalam, K.G.
1990
3 1 p. 80-
1 p.
artikel
45 Dopaminergic behavioral hypersensitivity in monkeys receiving long term neuroleptic treatment Casey, D.E.
1990
3 1 p. 79-80
2 p.
artikel
46 Editorial DeLisi, Lynn E.
1990
3 1 p. 3-4
2 p.
artikel
47 Editorial Board 1990
3 1 p. IFC-
1 p.
artikel
48 EEG brain mapping in schizophrenia and depression: Psychophyysiology as a maker for diagnosis and state Gallhofer, B.
1990
3 1 p. 53-
1 p.
artikel
49 EEG power spectral components of schizoaffective disorders Schellenberg, R.
1990
3 1 p. 54-
1 p.
artikel
50 Effect of chronic neuroleptic treatment on spontaneously active dopamine neurones in the A9 and A10 area of rat brain: Correlation to receptor profile? Hyttel, J.
1990
3 1 p. 50-51
2 p.
artikel
51 Effects of partial dopamine receptor agonists on the d-amphetamine discriminative cue Clark, D
1990
3 1 p. 84-85
2 p.
artikel
52 Elevated d2 receptor density in 23 schizophrenics Tune, L.E.
1990
3 1 p. 29-
1 p.
artikel
53 Ergopsychometry—Results of a stress load program in schizophrenics Gunther, V
1990
3 1 p. 68-69
2 p.
artikel
54 Evidence for independent transmission of genetic vulnerability and age of onset in schizophrenia Taylor, C.
1990
3 1 p. 13-
1 p.
artikel
55 Eye movement abnormality in schizoptypal personality disorder (SPD) Thaker, G.
1990
3 1 p. 59-
1 p.
artikel
56 Family history, obstetric complications and age at onset of schizophrenia: A case control study Jones, P.B.
1990
3 1 p. 8-
1 p.
artikel
57 Family studies in schizophrenia and affective disorders: Evidence for a continuum model Maier, W.
1990
3 1 p. 12-13
2 p.
artikel
58 Free radical involvement in schizophrenia and tardive dyskinesia Shriqui, C.L.
1990
3 1 p. 81-
1 p.
artikel
59 Free radicals, neuroleptic drugs and tardive dyskinesia Medley, I
1990
3 1 p. 81-82
2 p.
artikel
60 Gender differences in age-of-onset of schizophrenia and manic-depressive disease Papezova, H.
1990
3 1 p. 8-9
2 p.
artikel
61 Human data on an animal model of schizophrenia Lubow, R.E.
1990
3 1 p. 69-70
2 p.
artikel
62 ICI 204,636: A new and novel atypical antipsychotic drug Malick, J.B.
1990
3 1 p. 46-
1 p.
artikel
63 Indexing CNS receptor in schizophrencs by jointly assessing psychophysiological and catecholaminergic activity Olbrich, R.
1990
3 1 p. 58-
1 p.
artikel
64 Information processing in schizophrenai Weller, M.P.
1990
3 1 p. 61-
1 p.
artikel
65 Is low-EE a synonym for a protective familiar atmosphere in schizophrenia? Schulze-Monking, H
1990
3 1 p. 76-77
2 p.
artikel
66 Kinetics of oral clozapine Haring, C.
1990
3 1 p. 42-
1 p.
artikel
67 Lateralized symptomatology in schizophrenia: Anomalous visual experiences and body image disorders Cutting, J
1990
3 1 p. 74-
1 p.
artikel
68 Learning to live with schizophrenia: A new residential facility as an example for an emerging paradigm Katschnig, H
1990
3 1 p. 92-93
2 p.
artikel
69 Long-term treatment of chronic schizophrenia patients with risperidone Mertens, C.
1990
3 1 p. 48-
1 p.
artikel
70 Maine's replication of vermont's 32 years outcome study: Recent findings and surprising implications Harding, C.M.
1990
3 1 p. 9-10
2 p.
artikel
71 Maintenance treatment in schizophrenia: Current status in Austria Meise, U.
1990
3 1 p. 39-
1 p.
artikel
72 Mechanisms underlying abnormalities in verbal fluency in schizophrenia Allen, H
1990
3 1 p. 67-68
2 p.
artikel
73 Memory dysfunction in schizophrenia McKenna, P.J.
1990
3 1 p. 67-
1 p.
artikel
74 Mental effort in psychotic patients Schamand, B.
1990
3 1 p. 64-
1 p.
artikel
75 Mental effort in psychotic patients Kuipers, T
1990
3 1 p. 68-
1 p.
artikel
76 Minor sensoric and motoric disturbances (Neurological soft-signs) in remitting and chronic schizophrenia Schröder, J
1990
3 1 p. 93-94
2 p.
artikel
77 Modality-dependent post-imperative negative variations in schizophrenic patients Cohen, R
1990
3 1 p. 69-
1 p.
artikel
78 Nadolol treat aggression and psychiatric symptomatology in chronic psychiatric inpatients Ratey, J.
1990
3 1 p. 49-
1 p.
artikel
79 Neurochemical pathology in schizopherinia: Limbic deficits in GABA systems Reynolds, G.P.
1990
3 1 p. 34-
1 p.
artikel
80 Neuroleptic drug effects on cognitive function in schizophrenia Cleghorn, J.M.
1990
3 1 p. 64-65
2 p.
artikel
81 Neuropsychological indicators for the vulnerability to schizophrenia Maier, W.
1990
3 1 p. 62-
1 p.
artikel
82 Non-organic psychoses amongst Asian immigrants and English-born controls: A comparison of service utilization Gupta, S.
1990
3 1 p. 9-
1 p.
artikel
83 On the pathogenetic role of dopaminergic and serotonergic neurotransmission in longterm hospitalized psychotic patients Louwerens, J.W.
1990
3 1 p. 52-
1 p.
artikel
84 On the positive - negative distinction of schizophrenia: C orrelations between psychopathology and EEG brain mapping Kufferle, B.
1990
3 1 p. 53-54
2 p.
artikel
85 Ordering thoughts on thought disorder McGrath, J
1990
3 1 p. 73-
1 p.
artikel
86 P300 and eye movement disorder used as physiological markers in linkage studies in schizophrenia Blackwood, D.H.R.
1990
3 1 p. 55-
1 p.
artikel
87 P300 and processing negativity in schizophrenic illness: trait or state markers? Ward, P.B.
1990
3 1 p. 54-55
2 p.
artikel
88 Patients' reactions to psychoeducation and untoward effects van Meer, C.R.
1990
3 1 p. 88-
1 p.
artikel
89 Patterns of negative symptoms Kuipers, T
1990
3 1 p. 72-
1 p.
artikel
90 Patterns of schizophrenia in British Caribbeans Glover, G.R.
1990
3 1 p. 6-7
2 p.
artikel
91 Phencyclidine and sigma receptor abnormalities in schizophrenic post mortem brain 1990
3 1 p. 32-
1 p.
artikel
92 Photophobic and photomanic behavior in psychoses Gerbaldo, H
1990
3 1 p. 74-75
2 p.
artikel
93 Physical anomalies and neurodevelopmental abnormality in schizophrenia: New clinical correlates Waddington, J.L.
1990
3 1 p. 90-
1 p.
artikel
94 Physical Mapping of the schizophrenia-superconductivity locus (SCZI) on chromosome 5 using pulsed field gel electrophoresis Mankoo, B.S.
1990
3 1 p. 15-
1 p.
artikel
95 Plasma IgA antibodies against casein and other food antigens in schizophrenic patients and normal controls Lindstrom, L.H.
1990
3 1 p. 35-36
2 p.
artikel
96 Plasma polyamine oxidase in normal and schizophrenic subjects Das, I.
1990
3 1 p. 37-38
2 p.
artikel
97 Platelet model of abnormal signal transduction in schizophrenia Kaiya, H.
1990
3 1 p. 36-
1 p.
artikel
98 Positive and negative symptoms in chronic schizophrenia: A 1-year follow-up study Cazzullo, C.L.
1990
3 1 p. 72-
1 p.
artikel
99 Positron emission tomography and psychometry in schizophrenia Hashimoto, T
1990
3 1 p. 26-
1 p.
artikel
100 Post dose reduction survival in the maintenance treatment of schizophrenia Heresco-Levy, U.
1990
3 1 p. 39-40
2 p.
artikel
101 Post-mortem neurochemical studies of tardive dyskinesia Reynolds, G.P.
1990
3 1 p. 82-83
2 p.
artikel
102 Postmortem study of the dopaminergic d1 receptors in the dorsolateral prefrontal cortex of schizophrenics and controls Laurelle, M
1990
3 1 p. 30-31
2 p.
artikel
103 Predicting relapse of schizophrenic patients on the basis of camberwell family interview and gottschalk-gleser ratings: A failure to replicate Niedermeier, T
1990
3 1 p. 76-
1 p.
artikel
104 Predictors of outcome in chronic schizophrenia Azzone, P.
1990
3 1 p. 10-
1 p.
artikel
105 Pregnancy and birth complications as causes of psychiatric illness in adult life: A study utilizing the perinatal mortality survey (1958) Done, J
1990
3 1 p. 91-
1 p.
artikel
106 Preliminary findings in search of a genetic linkage of schizophrenia to a locus on chromosome 5 O'Neil, F.A.
1990
3 1 p. 14-
1 p.
artikel
107 Psychosis associated with demonstrable disease of the CNS Feinstein, A
1990
3 1 p. 89-90
2 p.
artikel
108 Putamen metabolic activity predicts dyskinesia severity in schizophrenic patients Holcomb, H.H.
1990
3 1 p. 82-
1 p.
artikel
109 Reduced cerebral volume in schizophrenia Nasrallah, H.A.
1990
3 1 p. 17-
1 p.
artikel
110 Reduced frontal area and poorer frontal functioning in schzophrenics: An MRI, neuropsychological and psychophysiological examination Raine, A
1990
3 1 p. 21-
1 p.
artikel
111 Reduced temporal lobe areas in schizophrenia: Preliminary evidences from a controlled multiplanar magnetic resonance study Rossi, A
1990
3 1 p. 21-22
2 p.
artikel
112 Regional cerebral metabolic activity in chronic schizophrenia Liddle, P.F.
1990
3 1 p. 23-24
2 p.
artikel
113 Regulation of the platelet polyphosphoinositide system by antipsychotic drugs: A specific neuroleptic action Essali, M.A.
1990
3 1 p. 36-37
2 p.
artikel
114 Rehabilitation-project assen-groningen: Cognitive dysfunction and social skills Apelo, M
1990
3 1 p. 66-67
2 p.
artikel
115 Relationship between premorbid characteristics, symptomatology and coping in first onset schizophrenics Thurm-Mussgay, I
1990
3 1 p. 71-
1 p.
artikel
116 Remoxipride — A selective dopamine D2 antagonist in the treatment of acute schizophrenia: a Canadian multicentre clinical trial Awad, A.G.
1990
3 1 p. 45-
1 p.
artikel
117 Remoxipride: Overview of results from a clinical evaluation programme in schizophrenia Lewander, T.
1990
3 1 p. 45-46
2 p.
artikel
118 Remoxipride versus haloperidol in the treatment of acute schizophrenia: The incidence and severity of extrapyramidal symptoms Morrison, D.
1990
3 1 p. 43-
1 p.
artikel
119 Right hemisphere function in schizoprenia and magic depression David, A.S.
1990
3 1 p. 74-
1 p.
artikel
120 Ritanserin in the treatment of neuroleptic-induced akathesia Fleischhacker, W.W.
1990
3 1 p. 47-
1 p.
artikel
121 Schizophrenia clusters in the north of Scotland from 1900–1960 Kerridge, D.
1990
3 1 p. 5-
1 p.
artikel
122 Search for cytomegalovirus in the post-mortem brains of schizophrenic patients using the polymerase chain reaction Alexander, R.C.
1990
3 1 p. 89-
1 p.
artikel
123 Selective dopamine D2 antagonist, remoxipride,in the treatment of acute schizophrenia - results of proclactin studies Awad, A.G.
1990
3 1 p. 43-
1 p.
artikel
124 Siblings of schizophrenia probands: Presence of neuropsychological impairments Pogue-Geile, M.
1990
3 1 p. 62-
1 p.
artikel
125 Significance of possitive and negative symptoms in chronic schizophrenics patients Maylath, E
1990
3 1 p. 71-
1 p.
artikel
126 Social behavior and cognitive function in chronic schizophrenia Liddle, P
1990
3 1 p. 65-66
2 p.
artikel
127 Somatosensory evoked potentials and sensorimotor processing in schizophrenic symptom types Davies, W.T.
1990
3 1 p. 57-58
2 p.
artikel
128 Some aspects of cognitive function in schizophrenia Landro, N.I.
1990
3 1 p. 63-
1 p.
artikel
129 Structural and functional characteristics of the corpus callosum in schzophrenics, psychiatric controls, and normal controls: An MRI and neuropsychological evaluation Raine, A
1990
3 1 p. 20-
1 p.
artikel
130 Studies on the mechanism(s) for the ‘atypical’ neuroleptic activity of remoxipride Ogren, S.O.
1990
3 1 p. 44-
1 p.
artikel
131 Study of monozygotic twins with psychosis Torrey, E.F.
1990
3 1 p. 90-91
2 p.
artikel
132 Subjective experience and response to clozapine Grimaldi, J.
1990
3 1 p. 42-
1 p.
artikel
133 Substance abuse and schizophrenia: Effects on symptoms but not on neurocognitive function Cleghorn, J.M.
1990
3 1 p. 65-
1 p.
artikel
134 Superior temporal gyrus volume in schizophrenia Barta, P.E.
1990
3 1 p. 22-
1 p.
artikel
135 Tardive dyskinesia and cognitive functions in schizophrenia Soni, S.D.
1990
3 1 p. 78-
1 p.
artikel
136 Tardive dyskinesia: Outcome at 10 years Casey, D.E.
1990
3 1 p. 11-
1 p.
artikel
137 The effects of alpha-tocopherol in schizophrenic patients treated with neuroleptics Fojtikova, I
1990
3 1 p. 93-
1 p.
artikel
138 The effects of dopamine agonests on CBF (133XE dynamic spect) and negative symptoms in schizophrenia Daniel, D.G.
1990
3 1 p. 28-
1 p.
artikel
139 The effects of neuroleptics on CBF and CMRO2 in schizophrenic patients: A study using pet Macda, T
1990
3 1 p. 26-
1 p.
artikel
140 The electrodermal orienting response in schizophrenics and its stability across different clinical states Mussgay, L.
1990
3 1 p. 59-
1 p.
artikel
141 The glutaminergic hypothesis of schizophrenia: A study using positron emission tomography Kishimoto, H
1990
3 1 p. 27-
1 p.
artikel
142 The influence of expressed emotion on autonomic and behavioral measures of schizophrenic patients and their relatives Schlenker, R
1990
3 1 p. 76-
1 p.
artikel
143 The natural history of schizotypal features and disorder Squires-Wheeler, E.
1990
3 1 p. 13-14
2 p.
artikel
144 The neurochemical anatomy of the hippocampus in post-mortem schizophrenic brain Kerwin, R.
1990
3 1 p. 33-34
2 p.
artikel
145 The premorbid adjustment of offendant and non-offendant schizophrenics Foldes, P.
1990
3 1 p. 75-
1 p.
artikel
146 The results of training of perceptual and cognitive functions with chronic schizophrenic patients Van der Gaag, M
1990
3 1 p. 66-
1 p.
artikel
147 The schizophrenias: Diseases in the basal ganglia or in the cortex? A study using pet Abe, H
1990
3 1 p. 27-28
2 p.
artikel
148 The South and North Camden schizophrenia surveys: The prevalence of schizophrenia by electoral ward and its relationship to social demographic factors Pantelis, C.
1990
3 1 p. 6-
1 p.
artikel
149 The validity of the ICD-10- and DSM-III-R-classification of psychotic disorders by family study data Mainer, W.
1990
3 1 p. 12-
1 p.
artikel
150 Three dimensional registration, display, and analysis of PET-MR images Holcomb, H.H.
1990
3 1 p. 23-
1 p.
artikel
151 Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenia outpatients: Clinical and social outcome at 2 years Hirsch, S.R.
1990
3 1 p. 40-
1 p.
artikel
152 Usefulness of an animal psychosis model Franzen, U
1990
3 1 p. 84-
1 p.
artikel
153 Ventricular system morphology in first episode schizophrenia: A volumetric study of ventricular subdivisions on MRI Degreef, G
1990
3 1 p. 18-
1 p.
artikel
154 White matter T1 times in schizophrenic patients and healthy controls on MRI scan Harvey, I
1990
3 1 p. 22-
1 p.
artikel
155 Why is schizophrenia disappearing? Murray, R.M.
1990
3 1 p. 5-
1 p.
artikel
                             155 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland